These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 34199494)
21. Upregulation of the endothelin A (ET McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604 [TBL] [Abstract][Full Text] [Related]
22. The molecular basis of retinal ganglion cell death in glaucoma. Almasieh M; Wilson AM; Morquette B; Cueva Vargas JL; Di Polo A Prog Retin Eye Res; 2012 Mar; 31(2):152-81. PubMed ID: 22155051 [TBL] [Abstract][Full Text] [Related]
23. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss. Nuschke AC; Farrell SR; Levesque JM; Chauhan BC Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986 [TBL] [Abstract][Full Text] [Related]
24. Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice. Harder JM; Williams PA; Soto I; Foxworth NE; Fernandes KA; Freeburg NF; Libby RT; John SWM Cell Death Dis; 2018 Jun; 9(6):705. PubMed ID: 29899326 [TBL] [Abstract][Full Text] [Related]
25. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model. Beirowski B; Babetto E; Coleman MP; Martin KR Eur J Neurosci; 2008 Sep; 28(6):1166-79. PubMed ID: 18783366 [TBL] [Abstract][Full Text] [Related]
27. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Bull ND; Irvine KA; Franklin RJ; Martin KR Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4244-53. PubMed ID: 19357352 [TBL] [Abstract][Full Text] [Related]
28. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062 [TBL] [Abstract][Full Text] [Related]
29. The Role of Axonal Transport in Glaucoma. Dias MS; Luo X; Ribas VT; Petrs-Silva H; Koch JC Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409291 [TBL] [Abstract][Full Text] [Related]
30. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Ebneter A; Chidlow G; Wood JP; Casson RJ Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677 [TBL] [Abstract][Full Text] [Related]
31. Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress. Ko JA; Komatsu K; Okumichi H; Kiuchi Y Cell Biochem Funct; 2021 Jan; 39(1):98-106. PubMed ID: 32613670 [TBL] [Abstract][Full Text] [Related]
32. Autophagy in axonal degeneration in glaucomatous optic neuropathy. Munemasa Y; Kitaoka Y Prog Retin Eye Res; 2015 Jul; 47():1-18. PubMed ID: 25816798 [TBL] [Abstract][Full Text] [Related]
33. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. Wax MB; Tezel G; Yang J; Peng G; Patil RV; Agarwal N; Sappington RM; Calkins DJ J Neurosci; 2008 Nov; 28(46):12085-96. PubMed ID: 19005073 [TBL] [Abstract][Full Text] [Related]
35. The challenge of regenerative therapies for the optic nerve in glaucoma. Calkins DJ; Pekny M; Cooper ML; Benowitz L; Exp Eye Res; 2017 Apr; 157():28-33. PubMed ID: 28153739 [TBL] [Abstract][Full Text] [Related]
36. Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma. Smith MA; Xia CZ; Dengler-Crish CM; Fening KM; Inman DM; Schofield BR; Crish SD J Comp Neurol; 2016 Dec; 524(17):3503-3517. PubMed ID: 27072596 [TBL] [Abstract][Full Text] [Related]
37. Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1. Zhu Y; Zhang L; Sasaki Y; Milbrandt J; Gidday JM Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):25-36. PubMed ID: 23211826 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering. Tribble JR; Hui F; Quintero H; El Hajji S; Bell K; Di Polo A; Williams PA Mol Aspects Med; 2023 Aug; 92():101193. PubMed ID: 37331129 [TBL] [Abstract][Full Text] [Related]
39. Optic neuropathies: the tip of the neurodegeneration iceberg. Carelli V; La Morgia C; Ross-Cisneros FN; Sadun AA Hum Mol Genet; 2017 Oct; 26(R2):R139-R150. PubMed ID: 28977448 [TBL] [Abstract][Full Text] [Related]
40. XIAP gene therapy effects on retinal ganglion cell structure and function in a mouse model of glaucoma. Visuvanathan S; Baker AN; Lagali PS; Coupland SG; Miller G; Hauswirth WW; Tsilfidis C Gene Ther; 2022 Apr; 29(3-4):147-156. PubMed ID: 34363035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]